Taking a page out of big pharma’s marketing playbook, Myriad Genetics this week launched a direct-to-consumer television advertising campaign aimed to educate women about the risk of inherited breast and ovarian cancer associated with BRCA1 and BRCA2 genetic mutations, and simultaneously, advertise its BRACAnalysis test.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.